Status:
WITHDRAWN
Phase 3 Study of the Biologic Lung Volume Reduction (BLVR) System in Advanced Upper Lobe Predominant (ULP) Emphysema
Lead Sponsor:
Aeris Therapeutics
Conditions:
Advanced Upper Lobe Predominant Emphysema
Phase:
PHASE3
Brief Summary
The purpose of the study is to evaluate the efficacy and safety of the 20 mL BLVR System in treating patients with advanced upper lobe predominant emphysema.
Detailed Description
Patients with emphysema currently have limited treatment choices. Many patients are treated with steroids and inhaled medications,which often provide little or no benefit. In recent years, lung volum...
Eligibility Criteria
Inclusion
Exclusion
Key Trial Info
Start Date :
December 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2009
Estimated Enrollment :
225 Patients enrolled
Trial Details
Trial ID
NCT00716053
Start Date
December 1 2008
End Date
December 1 2009
Last Update
January 18 2010
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.